Abstract
TCR-like chimeric antigen receptor (CAR-T) cell therapy has emerged as a game-changing strategy in cancer immunotherapy, offering a broad spectrum of ......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
